Vidisa Formulations Private Limited
About Vidisa Formulations Private Limited
Data last updated:
Vidisa Formulations Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 November 2022.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U33110WB2022PTC258135. Its GSTIN is 08AAJCV0682M1ZR (Rajasthan).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Birdichand Bajaj and Deeraj Bajaj.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 67 Bangur Avenue Block – D, Kolkata, West Bengal, India – 700055.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.14 Cr. For the same year it recorded a net loss of ₹91.67 Lakh (net margin -42.9%) and EBITDA of -₹14.95 Lakh (EBITDA margin -7%).
As per MCA filings, the company has open charges of ₹2.5 Cr on record.
Company details
Contact details
Vidisa Formulations Private Limited's registered office is in Kolkata, West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address67 Bangur Avenue Block – D, Kolkata, West Bengal, India – 700055
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Vidisa Formulations Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Vidisa Formulations is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Vidisa Formulations Private Limited, buy the company report.
Financials of Vidisa Formulations Private Limited
FY 2025 filings availableVidisa Formulations Private Limited reported revenue of ₹2.14 Cr for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹14.95 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹91.67 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -7% | ||
| Net Profit Margin | -42.9% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Vidisa Formulations Private Limited, buy the company report.
Board of directors of Vidisa Formulations Private Limited
Vidisa Formulations has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Birdichand Bajaj | Director | 11 Nov 2022 | 3 Years 11 Months | Current |
| Deeraj Bajaj | Director | 11 Nov 2022 | 3 Years 11 Months | Current |
| Suresh Kumar Bajaj | Director | 11 Nov 2022 | 3 Years 11 Months | Current |
Auditor
Vidisa Formulations Private Limited is audited by AGRAWAL MANISH & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AGRAWAL MANISH & CO. | FY 2023 | 323190E |
Shareholding
The shareholding of Vidisa Formulations Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Vidisa Formulations Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Jun 2023 | 100747756 | Others | ₹2.5 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Vidisa Formulations Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vidisa Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Vidisa Formulations Private Limited has 1 active EPFO establishment as of Mar 29, 2024.
GST
Vidisa Formulations has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAJCV0682M1ZR | Rajasthan | Active | 31 May 2023 |
To see the full GST registrations and return filing status of Vidisa Formulations Private Limited, buy the company report.
Recent activity
Vidisa Formulations Private Limited has 3 board changes on record since 2022: 3 appointments. The latest: Birdichand Bajaj was appointed as Director on 11 Nov 2022.
Frequently asked questions
Vidisa Formulations is an active private limited company based in Kolkata, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 November 2022 (4+ years old) and is registered under CIN U33110WB2022PTC258135.
Vidisa Formulations has 3 current directors:
- Birdichand Bajaj - Director
- Deeraj Bajaj - Director
- Suresh Kumar Bajaj - Director
The latest financial statements of Vidisa Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Vidisa Formulations is 08AAJCV0682M1ZR, registered in Rajasthan.
The CIN (Corporate Identification Number) of Vidisa Formulations is U33110WB2022PTC258135. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vidisa Formulations was incorporated on 11 November 2022, making it 4+ years old. It is registered with the Registrar of Companies, Kolkata.
Birdichand Bajaj was appointed as Director on 11 Nov 2022. Deeraj Bajaj was appointed as Director on 11 Nov 2022. Suresh Kumar Bajaj was appointed as Director on 11 Nov 2022.
The registered office of Vidisa Formulations is at 67 Bangur Avenue Block – D, Kolkata, West Bengal, India – 700055.
Vidisa Formulations operates in the pharma industry, in the drug formulation and development segment.
Vidisa Formulations has open charges of ₹2.5 Cr and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
